Cargando…

Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival

The family of Toll-like receptors (TLRs) is critical in linking innate and acquired immunity. Polymorphisms in the genes encoding TLRs have been associated with autoimmune diseases and cancer. We investigated the genetic variation of TLR genes and its potential impact on melanoma susceptibility and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gast, Andreas, Bermejo, Justo Lorenzo, Claus, Rainer, Brandt, Andreas, Weires, Marianne, Weber, Alexander, Plass, Christoph, Sucker, Antje, Hemminki, Kari, Schadendorf, Dirk, Kumar, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170315/ https://www.ncbi.nlm.nih.gov/pubmed/21931695 http://dx.doi.org/10.1371/journal.pone.0024370

Ejemplares similares

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
por: Bouwhuis, Marna G., et al.
Publicado: (2009)

Socio-economic status and overall and cause-specific mortality in Sweden
por: Weires, Marianne, et al.
Publicado: (2008)

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts
por: Xie, Huaping, et al.
Publicado: (2016)

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes
por: Hemminki, Kari, et al.
Publicado: (2010)

B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis
por: Ugurel, Selma, et al.
Publicado: (2007)

Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events
por: Hemminki, Kari, et al.
Publicado: (2005)

Variants at the 9p21 locus and melanoma risk
por: Maccioni, Livia, et al.
Publicado: (2013)

Influence of family size and birth order on risk of cancer: a population-based study
por: Bevier, Melanie, et al.
Publicado: (2011)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

Lack of SF3B1 R625 mutations in cutaneous melanoma
por: Schilling, Bastian, et al.
Publicado: (2013)

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
por: Willmes, Christoph, et al.
Publicado: (2016)

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients
por: Schrama, David, et al.
Publicado: (2014)

Inherited variation in the PARP1 gene and survival from melanoma
por: Davies, John R, et al.
Publicado: (2014)

The ‘Common Disease-Common Variant’ Hypothesis and Familial Risks
por: Hemminki, Kari, et al.
Publicado: (2008)

Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database
por: Bermejo, Justo Lorenzo, et al.
Publicado: (2004)

ARLTS1 polymorphisms and basal cell carcinoma of the skin
por: Li, Xuchen, et al.
Publicado: (2007)

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study
por: Davies, John R, et al.
Publicado: (2012)

The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence
por: Hemminki, Kari, et al.
Publicado: (2006)

Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
por: Thier, Beatrice, et al.
Publicado: (2022)

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
por: Peiffer, Lukas, et al.
Publicado: (2020)

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA
por: Stiller, Mathias, et al.
Publicado: (2016)

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
por: Davies, John R, et al.
Publicado: (2014)

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
por: Cosgarea, Ioana, et al.
Publicado: (2017)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma
por: Váraljai, Renáta, et al.
Publicado: (2021)

Risk of other Cancers in Families with Melanoma: Novel Familial Links
por: Frank, Christoph, et al.
Publicado: (2017)

Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
por: Nsengimana, Jérémie, et al.
Publicado: (2015)

Analysis of SDHD promoter mutations in various types of melanoma
por: Scholz, Simone L., et al.
Publicado: (2015)

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
por: Wagner, Nikolaus B., et al.
Publicado: (2019)

Lack of clinical efficacy of imatinib in metastatic melanoma
por: Ugurel, S, et al.
Publicado: (2005)

Familial Risks and Mortality in Second Primary Cancers in Melanoma
por: Chattopadhyay, Subhayan, et al.
Publicado: (2019)

Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
por: Albrecht, Lea Jessica, et al.
Publicado: (2022)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

Modification of second cancer risk after malignant melanoma by parental history of cancer
por: Zhang, H, et al.
Publicado: (2008)

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
por: Hegedüs, Luca, et al.
Publicado: (2022)

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
por: Hassel, J C, et al.
Publicado: (2010)

Second Primary Cancers in Melanoma Patients Critically Shorten Survival
por: Zheng, Guoqiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i8fi3mrgq39t8rgu2m52bhcv16